These Consumer Stocks Are Getting a Lift as Investors Rotate Out of Tech
Some beaten-down consumer names are getting a boost as investors pull back from tech stocks.
Investopedia10/15/2026Negative
AMGN
Amgen IncNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$233.82B
P/E Ratio
26.86
EPS
$16.10
Beta
0.41
52W High
$447.03
52W Low
$280.23
50-Day MA
$415.01
200-Day MA
$368.90
Dividend Yield
2.26%
Profit Margin
23.00%
Forward P/E
16.67
PEG Ratio
2.45
About Amgen Inc
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Fundamentals
| Revenue (TTM) | $38.09B |
| Gross Profit (TTM) | $27.39B |
| EBITDA | $17.27B |
| Operating Margin | 35.50% |
| Return on Equity | 91.50% |
| Return on Assets | 8.67% |
| Revenue/Share (TTM) | $70.68 |
| Book Value | $21.62 |
| Price-to-Book | 18.78 |
| Price-to-Sales (TTM) | 6.14 |
| EV/Revenue | 6.9 |
| EV/EBITDA | 14.92 |
| Quarterly Earnings Growth (YoY) | 64.90% |
| Quarterly Revenue Growth (YoY) | 9.50% |
| Shares Outstanding | $540.63M |
| Float | $539.16M |
| % Insiders | 0.23% |
| % Institutions | 85.12% |
Historical Volatility
HV 10-Day
24.84%
HV 20-Day
28.96%
HV 30-Day
41.57%
HV 60-Day
35.15%
HV Rank
99.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($394.98 target)
4
Strong Buy8
Buy17
Hold3
Sell2
Strong SellLatest News
AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow
Amgen and Merck both yield around 2.3% and have surged this year, but one of them is paying its dividend out of thin air while the other has a cash cushion that changes the entire income calculus.
24/7 Wall Street10/15/2026Positive
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
Every big pharma company eventually watches its best-selling drug go generic, yet some keep raising their dividends anyway.
24/7 Wall Street10/14/2026Positive
Here's Why Amgen (AMGN) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research10/13/2026Positive
Amgen (AMGN) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Amgen (AMGN) stood at $413.08, denoting a +2.6% move from the preceding trading day.
Zacks Investment Research10/7/2026Neutral
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks Investment Research10/6/2026Positive
Amgen (AMGN) Stock Dips While Market Gains: Key Facts
Amgen (AMGN) closed at $407.27 in the latest trading session, marking a -3.38% move from the prior day.
Zacks Investment Research10/1/2026Neutral
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
LLY and Novo face off at EASD as new data fuels the GLP-1 market, while ETFs offer diversified exposure to weight loss drug growth.
Zacks Investment Research10/1/2026Positive
Why Amgen's 6% Dividend Raise Masks a Tougher Road Ahead
Amgen just handed income investors another dividend raise, but a mountain of acquisition debt, crumbling legacy drugs, and a billion-dollar obesity bet are all competing for the same pool of cash.
24/7 Wall Street9/29/2026Neutral
Take the Zacks Approach to Beat the Markets: Bloom Energy, Microsoft & Amgen in Focus
Microsoft, Bloom Energy and Amgen highlight Zacks' latest market moves, with strong gains across Focus List, recommendation and dividend portfolios.
Zacks Investment Research9/28/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMGN and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 10/17/2026